ストックスクリーナーアプリを入手
3.64
1.36%
-0.05
アフターアワーズ：
3.63
-0.01
-0.27%
前日終値:
$3.69
開ける：
$3.7
24時間の取引高:
3.12M
Relative Volume:
0.60
時価総額：
$870.91M
収益：
$251.85M
当期純損益:
$-72.58M
株価収益率:
-11.61
EPS:
-0.3134
ネットキャッシュフロー:
$-63.80M
1週間 パフォーマンス:
-9.68%
1か月 パフォーマンス:
-2.54%
6か月 パフォーマンス:
-33.82%
1年 パフォーマンス:
-48.95%
1日の値動き範囲:
$3.62
$3.76
1週間の範囲:
$3.5701
$4.01
52週間の値動き範囲:
$3.21
$8.06
Ardelyx Inc Stock (ARDX) Company Profile
ARDX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
3.64 | 964.20M | 251.85M | -72.58M | -63.80M | -0.3134 |
|
ONC
Beone Medicines Ltd Adr
|
257.00 | 26.69B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
443.82 | 114.81B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.282 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
85.54 | 6.60B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
483.07 | 65.36B | 14.09B | 4.50B | 2.96B | 39.28 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-02 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | 再開されました | Ladenburg Thalmann | Buy |
| 2025-03-04 | 開始されました | BTIG Research | Buy |
| 2024-11-11 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | 開始されました | Leerink Partners | Outperform |
| 2023-12-18 | 開始されました | Raymond James | Strong Buy |
| 2023-09-07 | 開始されました | H.C. Wainwright | Buy |
| 2023-08-25 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | アップグレード | Wedbush | Neutral → Outperform |
| 2022-11-17 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | ダウングレード | Jefferies | Buy → Hold |
| 2021-07-20 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | ダウングレード | Wedbush | Outperform → Neutral |
| 2021-03-23 | 開始されました | Wedbush | Outperform |
| 2021-01-06 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-10-20 | 再開されました | Citigroup | Buy |
| 2020-02-18 | 再開されました | Jefferies | Buy |
| 2020-02-12 | 開始されました | Citigroup | Buy |
| 2020-02-10 | 開始されました | Cowen | Outperform |
| 2019-04-08 | 開始されました | Piper Jaffray | Overweight |
| 2018-08-24 | 開始されました | Jefferies | Buy |
| 2018-03-19 | 再開されました | Leerink Partners | Outperform |
| 2017-11-29 | 繰り返されました | Citigroup | Buy |
| 2017-11-22 | 繰り返されました | Ladenburg Thalmann | Buy |
| 2017-10-17 | 再開されました | Leerink Partners | Outperform |
| 2016-03-31 | 開始されました | Ladenburg Thalmann | Buy |
| 2016-03-09 | 開始されました | Cantor Fitzgerald | Buy |
| 2016-03-03 | 開始されました | Citigroup | Buy |
すべてを表示
Ardelyx Inc (ARDX) 最新ニュース
Transcript : Ardelyx, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 08 - marketscreener.com
Ardelyx at Jefferies Conference: Strategic Growth and Market Challenges - Investing.com
Ardelyx is hiring: Director, Marketing in Waltham at Ardelyx Job - Mediabistro
Ardelyx reshuffles leadership, adds new HR chief By Investing.com - Investing.com South Africa
Ardelyx appoints Mike Kelliher Chief Business Officer - TipRanks
Ardelyx Promotes Mike Kelliher to Chief Business Officer - marketscreener.com
Ardelyx (ARDX) Appoints New Leadership in Strategic Roles | ARDX Stock News - GuruFocus
Ardelyx Appoints Mike Kelliher Chief Business Officer - marketscreener.com
Ardelyx Appoints Mike Kelliher Chief Business Officer and James - GuruFocus
Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer | ARDX Stock News - GuruFocus
Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer - TradingView
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. ... - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cable One, Inc. - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc.ARDX - WV News
Ardelyx, Inc. (ARDX) Stock Analysis: Investors Eye a Promising 167.99% Upside Potential - DirectorsTalk Interviews
Learn to Evaluate (ARDX) using the Charts - news.stocktradersdaily.com
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Boosts Holdings in Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
2 ‘Strong Buy’ Small-Cap Stocks With Blockbuster Potential - The Globe and Mail
Deutsche Bank AG Boosts Position in Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
Ardelyx chief medical officer sells shares worth $26,206 By Investing.com - Investing.com South Africa
Ardelyx CFO sells $29,459 in stock By Investing.com - Investing.com South Africa
Ardelyx chief medical officer sells shares worth $26,206 - Investing.com Australia
Ardelyx officer Mike Kelliher sells $59,270 in stock By Investing.com - Investing.com South Africa
Ardelyx CFO sells $29,459 in stock - Investing.com Australia
Ardelyx officer Mike Kelliher sells $59,270 in stock - Investing.com Australia
Ardelyx Executives Sell Shares to Cover Taxes - TradingView
Levi & Korsinsky Reminds Ardelyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - ACCESS Newswire
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025 | ARDX Stock News - GuruFocus
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025 - The Manila Times
Ardelyx CEO Mike Raab to Share Company Vision at Major Healthcare Conference 2025 - Stock Titan
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Ardelyx, Inc.(ARDX) Shareholders - ACCESS Newswire
BNP Paribas Financial Markets Boosts Holdings in Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
Director David Mott Acquires 100,000 Shares of Ardelyx Inc (ARDX) - GuruFocus
Ardelyx falls 14% as Q1 results miss on both lines - MSN
Northern Trust Corp Purchases 50,441 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
The Manufacturers Life Insurance Company Sells 130,801 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
Benign Growth For Ardelyx, Inc. (NASDAQ:ARDX) Underpins Stock's 28% Plummet - simplywall.st
Investors Who Lost Money on Ardelyx, Inc. Should Contact Levi & Korsinsky About an Ongoing InvestigationARDX - ACCESS Newswire
Investors who Lost Money on Ardelyx, Inc. Should Contact Levi & Korsinsky About an Ongoing InvestigationARDX - ACCESS Newswire
I Have a Prescription for These Two Biopharmas That Fell After Earnings - TheStreet Pro
Cantor Fitzgerald Forecasts Reduced Earnings for Ardelyx - Defense World
Ardelyx, Inc. (NASDAQ:ARDX) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Ardelyx, Inc. (ARDX) - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Ardelyx LawsuitARDX - ACCESS Newswire
Ardelyx, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Ardelyx, Inc. (ARDX) - ACCESS Newswire
David Mott Bought 19% More Shares In Ardelyx - simplywall.st
Shareholders that lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class ActionARDX - ACCESS Newswire
Ardelyx Inc (ARDX) 財務データ
収益
当期純利益
現金流量
EPS
Ardelyx Inc (ARDX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Renz Justin A | Chief Financial Officer |
May 20 '25 |
Sale |
4.08 |
7,218 |
29,460 |
416,089 |
| RAAB MICHAEL | President & CEO |
May 20 '25 |
Sale |
4.08 |
46,817 |
191,079 |
1,547,937 |
| Kelliher Mike | See Remarks |
May 20 '25 |
Sale |
4.08 |
14,522 |
59,270 |
282,158 |
| GRAMMER ELIZABETH A | See Remarks |
May 20 '25 |
Sale |
4.08 |
5,992 |
24,456 |
311,731 |
| Foster Eric Duane | Chief Commercial Officer |
May 20 '25 |
Sale |
4.08 |
2,507 |
10,232 |
316,806 |
| MOTT DAVID M | Director |
May 15 '25 |
Buy |
3.29 |
100,000 |
329,120 |
2,496,871 |
| MOTT DAVID M | Director |
May 02 '25 |
Buy |
4.22 |
381,377 |
1,610,936 |
2,396,871 |
| RAAB MICHAEL | President & CEO |
May 02 '25 |
Option Exercise |
0.99 |
20,833 |
20,625 |
1,636,420 |
| RAAB MICHAEL | President & CEO |
May 02 '25 |
Sale |
4.25 |
41,666 |
177,168 |
1,594,754 |
0.86%
1.24%
大文字化:
|
ボリューム (24 時間):